Improving infection prevention in hospitals through better staffing.
Official title: Prevention of Infections Through Appropriate Staffing (PITAS)
Funded at Villanova University · NIH-10885030 · Data updated 2026-11-12
This study is looking at how having the right number of staff in infection prevention teams can help lower the number of infections people get while in the hospital, especially after the challenges posed by COVID-19, so that hospitals can keep patients safer.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Villanova University NIH-funded |
| Lab location | 1 site (Villanova, United States) |
| Project start | August 1, 2022 |
| Project end | July 31, 2026 |
| Funding year | 2024 |
| Award (this year) | $444,435 |
| NIH project number | 7R01HS029023-03 |
| Project ID | NIH-10885030 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are patients receiving care in acute care hospitals, particularly those at risk for healthcare-associated infections.
✕Less likely to help
Patients who are not currently hospitalized or those receiving outpatient care may not benefit directly from this research.
What this research studies
This research investigates how appropriate staffing levels in infection prevention and control (IPC) departments can reduce healthcare-associated infections (HAIs) in hospitals. It aims to understand the changes in IPC programs over time and assess the impact of the COVID-19 pandemic on infection rates and IPC resources. By using a mixed-method approach, the study will gather both quantitative and qualitative data to evaluate the effectiveness of current IPC practices and staffing. The findings could help hospitals implement better staffing strategies to enhance patient safety.
Why it matters
Potential benefit: If successful, this research could lead to improved infection control practices in hospitals, ultimately reducing the rates of healthcare-associated infections and enhancing patient safety.
How similar studies have gone: Previous research has shown that effective staffing in infection prevention can significantly reduce infection rates, indicating that this approach has potential for success.
Where this research is happening
-
Villanova University
Villanova, United States Active
Researchers
- Principal investigator: Pogorzelska-Maziarz, Monika — Villanova University
- Study coordinator: Pogorzelska-Maziarz, Monika
Related research
Other NIH-funded projects on the same topics.
-
Dyadic transplant self-care: how caregivers shape outcomes
A study will look at how patients awaiting lung transplants and their caregivers work together to manage post-transplant care and what this means for health and recovery.
-
Understanding how UPF1 controls RNA decay to help treat genetic diseases
A study at Villanova University looks at how a key RNA-helicase, UPF1, decides which RNA messages get destroyed, with the aim of someday influencing gene messages linked to diseases.
-
How the flagellum controls signaling, attachment, and dormancy in parasite infections
A study using a parasite model to understand how the flagellum affects signaling, sticking to surfaces, and life-stage changes that enable infection.
-
Repairing the cartilage protective layer to help osteoarthritis
Researchers are developing lab-made molecules that mimic cartilage sugars to rebuild the tiny protective layer around joint cells for people with osteoarthritis.
-
Using advanced imaging and AI to assess cognitive decline in older adults
This study is working on a new mobile app that uses advanced brain imaging and AI to help doctors better understand and diagnose mild cognitive impairment in older adults, making it easier to find the right care and support for those experiencing memory issues.
-
Targeted delivery of siRNA to treat kidney damage after blood flow restoration
This study is looking at a new way to help protect kidneys from damage that can happen during organ transplants by using tiny particles to deliver special treatments directly to the kidney cells, with the goal of reducing inflammation and improving how the blood vessels work.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.